These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10615731)

  • 21. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for HIV-1 seroprevalence among drug injectors in the cocaine-using environment of Rio de Janeiro.
    Lima ES; Friedman SR; Bastos FI; Telles PR; Friedmann P; Ward TP; des Jarlais DC
    Addiction; 1994 Jun; 89(6):689-98. PubMed ID: 8069170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.
    Phukan SK; Medhi GK; Mahanta J; Adhikary R; Thongamba G; Paranjape RS; Akoijam BS
    Harm Reduct J; 2017 Jul; 14(1):41. PubMed ID: 28673303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Malaria in intravenous drug users associated with HIV seropositivity].
    Lo SS; de Andrade JC; Condino ML; Alves MJ; Semeghini MG; Galvão Eda C
    Rev Saude Publica; 1991 Feb; 25(1):17-22. PubMed ID: 1784955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5").
    Aceijas C; Oppenheimer E; Stimson GV; Ashcroft RE; Matic S; Hickman M
    Addiction; 2006 Sep; 101(9):1246-53. PubMed ID: 16911723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.
    Teixeira SL; Bastos FI; Hacker MA; Morgado MG
    Infect Genet Evol; 2009 Jul; 9(4):638-42. PubMed ID: 19460331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug use, harm reduction, and health policies in Argentina: obstacles and new perspectives.
    Inchaurraga S
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S366-71. PubMed ID: 14648449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral manifestations of HIV infection: a Panamerican perspective.
    Gillespie GM; Mariño R
    J Oral Pathol Med; 1993 Jan; 22(1):2-7. PubMed ID: 7678293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An experiential program to reduce AIDS risk among female sex partners of injection-drug users.
    Rhodes F; Wolitski RJ; Thornton-Johnson S
    Health Soc Work; 1992 Nov; 17(4):261-72. PubMed ID: 1478552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of national highway with injecting drug abuse and HIV in rural Manipur, India.
    Sarkar K; Panda S; Das N; Sarkar S
    Indian J Public Health; 1997; 41(2):49-51. PubMed ID: 9988977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "The first shot": the context of first injection of illicit drugs, ongoing injecting practices, and hepatitis C infection in Rio de Janeiro, Brazil.
    Oliveira ML; Hacker MA; Oliveira SA; Telles PR; O KM; Yoshida CF; Bastos FI
    Cad Saude Publica; 2006 Apr; 22(4):861-70. PubMed ID: 16612439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clean needles save lives. HIV and injecting drug use.
    James B
    AIDS Action; 1993; (21):4-5. PubMed ID: 12345208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Outbreak of malaria induced among users of injectable drugs].
    Barata LC; Andriguetti MT; de Matos MR
    Rev Saude Publica; 1993 Feb; 27(1):9-14. PubMed ID: 8310273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous drug abuse speeds the spread of AIDS.
    Netw Res Triangle Park N C; 1988; 10(2):4-5. PubMed ID: 12342120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for intravenous drug use and sharing equipment among young male drug users in Longchuan County, south-west China.
    Wu Z; Detels R; Zhang J; Duan S; Cheng H; Li Z; Dong L; Huang S; Jia M; Bi X
    AIDS; 1996 Aug; 10(9):1017-24. PubMed ID: 8853736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The global diffusion of injecting drug use: implications for human immunodeficiency virus infection.
    Stimson GV
    Bull Narc; 1993; 45(1):3-17. PubMed ID: 8305905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV and HTLV-I infections in the Americas: a regional perspective.
    Quinn TC; Zacarias FR; St John RK
    Medicine (Baltimore); 1989 Jul; 68(4):189-209. PubMed ID: 2544782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection.
    Panda S; Saha U; Pahari S; Nathan M; Poddar S; Neogi D; Sarkar M; Pal NK; Mahalanabis D
    Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epidemiology of HIV infection among injecting drug users and other risk populations in Thailand.
    Nelson KE
    AIDS; 1994 Oct; 8(10):1499-500. PubMed ID: 7818824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions.
    Strathdee SA; Stockman JK
    Curr HIV/AIDS Rep; 2010 May; 7(2):99-106. PubMed ID: 20425564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.